Antibodies

17 Aug 2009 Avastin Plus Commonly Used Chemotherapies Improved Progression-Free Survival (PFS) in Women with Previously Treated Advanced Breast Cancer
14 Aug 2009 Amgen Issues Statement on Outcomes of Advisory Committee for Reproductive Health Drugs (ACRHD) Meeting
14 Aug 2009 Immunomedics Announces FDA Allowance of Investigational New Drug Application for Milatuzumab-Doxorubicin Conjugate
11 Aug 2009 BioInvent Announces Approval to start Phase I Trial for BI-505 in Multiple Myeloma
11 Aug 2009 GENMAB ANNOUNCES PRELIMINARY TOP-LINE RESULTS FOR ARZERRA™ IN FRONT LINE CLL
10 Aug 2009 MedImmune Advances Three Oncology Programs Into the Clinic
09 Aug 2009 Vectibix(R) in Combination With Chemotherapy Significantly Improved Progression-Free Survival in First-Line Metastatic Colorectal Cancer
07 Aug 2009 Antisoma announces discontinuation of development of AS1402
05 Aug 2009 FDA: Cancer Warnings Required for TNF Blockers
05 Aug 2009 PharmaGap Releases Results of Initial Testing For Novel Cancer Drug Compound at the Ottawa Hospital Research Institute
04 Aug 2009 Amgen Announces Positive Top-Line Results for Denosumab in Trial for Delay of Skeletal Related Events in Bone Metastases Patients Compared to Zometa(R)
04 Aug 2009 Facet Biotech Announces Daclizumab Program in Multiple Sclerosis to Advance
03 Aug 2009 Merck KGaA Presented New Data On the Combination of Erbitux with Standard First-Line Therapy in Patients with NSCLC
03 Aug 2009 FDA Approves Avastin for the Most Common Type of Kidney Cancer
31 Jul 2009 Update on FDA Registration of Actemra®, a Humanized Anti-Human IL-6 Receptor Monoclonal Antibody for Rheumatoid Arthritis
31 Jul 2009 BioInvent signs Licensing Agreement with Mitsubishi Tanabe Pharma Corporation for the Discovery and Development of Therapeutic Antibodies
31 Jul 2009 Merck KGaA Has Requested Re-examination of the CHMP Opinion for Erbitux in Non-Small Cell Lung Cancer
31 Jul 2009 ImmunoGen Announces Encouraging New Clinical Data with the Company's IMGN901 Compound in the Treatment of Small-Cell Lung Cancer
30 Jul 2009 GLAXOSMITHKLINE AND GENMAB ANNOUNCE TOP-LINE RESULTS FOR OFATUMUMAB IN RHEUMATOID ARTHRITIS
30 Jul 2009 Debiopharm and MSM Protein Technologies sign agreement for Research and Development of Debio 0929, a Novel Oncology Biologic
30 Jul 2009 Merck Serono and MSM Protein Technologies Establish Drug Discovery Collaboration Targeted to Complex Cell Surface Receptors
30 Jul 2009 Second Phase III Study Showed Lucentis Improved Vision in Patients with Retinal Vein Occlusion
30 Jul 2009 ArmaGen engineers IgG-decoy receptor fusion protein
29 Jul 2009 BTG plc: AstraZeneca to progress CytoFab™ into Phase IIb study
29 Jul 2009 European commission approves broader label for Avastin allowing combination with docetaxel for the first-line treatment of advanced (metastatic) breast cancer

La Merie Biologics

FREE Weekly News Bulletin

Sign Up

2021 Sales ofAntibodies & Proteins

New Product Alert

For La Merie Publishing

Sign Up

Top